Craig A. Collard is CEO at HERON THERAPEUTICS, INC. /DE/ (HRTX). They have made 10 open-market trades across 4 companies since 2009, most recently 2026-07-31.
CIK 0001363558
7 open-market purchases totalling $1.6M since 2021, against 3 sales. Across 7 scored buys the stock is up 41.7% at ninety days, and 37.0 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 86% | 57% | 57% |
| Avg Move | +10.4% | +9.1% | +41.7% |
| Alpha | +9.4% | +10.6% | +37.0% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRTX | BUY | 2023-11-16 | 2023-11-17 | $0.92 | $138K | +8.8% | +54.0% | +154.9% |
| OPNT | BUY | 2022-06-10 | 2022-06-13 | $11.10 | $63K | +13.0% | +6.1% | -1.8% |
| OPNT | BUY | 2022-05-16 | 2022-05-17 | $13.54 | $368K | -1.6% | -20.1% | -14.0% |
| OPNT | BUY | 2022-05-13 | 2022-05-16 | $10.49 | $39K | +6.5% | -13.6% | -2.9% |
| SRRA | BUY | 2021-11-23 | 2021-11-24 | $23.03 | $622K | +0.4% | -5.8% | +33.8% |
| OPNT | BUY | 2021-09-13 | 2021-09-15 | $18.13 | $45K | +11.3% | +3.9% | +48.0% |
| OPNT | BUY | 2021-09-10 | 2021-09-13 | $18.18 | $348K | +34.0% | +39.6% | +73.7% |
| CRTX | SELL | 2012-04-03 | 2012-04-03 | $6.25 | $9.0M | +30.4% | +64.5% | +64.5% |
| CRTX | SELL | 2010-12-16 | 2010-12-20 | $6.02 | $2.3M | +30.4% | +64.5% | +64.5% |
| CRTX | SELL | 2009-07-28 | 2009-07-30 | $5.50 | $6.9M | +30.4% | +64.5% | +64.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.